APPLICATION
ANDA201442
TYPE
ANDA
ORIGINAL APPROVAL
2022-06-27
LATEST ACTION
2022-06-27
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
LUBIPROSTONEDiscontinued
LUBIPROSTONE 24MCG · CAPSULE · ORAL
LUBIPROSTONEDiscontinued
LUBIPROSTONE 8MCG · CAPSULE · ORAL
Approval history
2022-06-27UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.